Hot Stocks

Hot stocks are not about hype. They emerge when powerful themes, policy shifts, and capital flows converge. InvestorPlace analysts track fast-moving market narratives, especially in technology, AI, and infrastructure, to identify stocks drawing outsized attention and explain what is really driving those moves.

Can Dunkin Brands Group Inc Stock Survive Its Latest Beating?

By Dana Blankenhorn, InvestorPlace Contributor
Dunkin Brands (DNKN) is expanding its store base as it seeks growth, and there are rumors of a takeover, but this is unlikely to matter in a down market. Here's what you need to know about DNKN stock after earnings.

Dunkin Brands Group Inc Stock Dips on Disappointing Sales

By William White, InvestorPlace Writer
Dunkin Brands (DNKN) stock was slipping Tuesday following the release of its earnings report for the fourth quarter of 2017.

Stellar Earnings Growth Keeps Nvidia (NVDA) a Strong Buy at recent price of $213.7

By Portfolio Grader
The Strong Buy recommendation for Nvidia Corp is the outcome of a proprietary process of evaluation which generated conclusions that were above average in 6 areas: an economic sector rated above average in attractiveness, an industry group rated above average in attractiveness, a ranking in the company's sector that is in the top quarter, ranking in its industry group that is in the top decile, a numerical calculation of risk/reward that is very attractive and analytical scores that are above average.

Solid Earnings Momentum Make Coca-Cola (KO) a Buy at recent price of $44.89

By Portfolio Grader
The a Buy rating for KO is based on the Portfolio Grader stock evaluator. This analytical tool researches stocks by means of fundamental and quantitative analytical. The current Portfolio Grader recommendation on the shares has been in place for 4 months.

General Motors Company Stock Gains on Q4 Earnings Beat

By William White, InvestorPlace Writer
General Motors (GM) stock was up Tuesday following the release of its earnings report for the fourth quarter of the year.

Dismal Quant Score Keep Kinder Morgan (KMI) a Strong Sell at recent price of $16.81

By Portfolio Grader
KMI is rated as a Strong Sell by means of the Portfolio Grader stock evaluator. The system for fundamental and quantitative metrics used in this analytical tool evaluates and ranks nearly 5,000 stocks each week. This represents no change from the previous week and is the same ranking KMI has had from Portfolio Grader for the last month.

Superior Earnings Visibility Metrics Drive Ranking of JPMorgan Chase & Co (JPM) to Buy at recent price of $108.8

By Portfolio Grader
Portfolio Grader currently ranks JPM as a Buy. This analytical tool assesses stocks by means of fundamental and quantitative algorithmic. The shares have been upgraded from a Hold to a Buy in the last week.

Fading Quant Score Downgrades Freeport-McMoRan (FCX) to Hold at recent price of $17.65

By Portfolio Grader
Portfolio Grader currently ranks FCX as a Hold. With proprietary fundamental and quantitative metric based, this analytical tool researches nearly 5,000 stocks weekly. FCX has been downgraded from a Buy to a Hold in the last week.

Rating on Facebook (FB) Upgraded to Strong Buy From a Buy at recent price of $181.26

By Portfolio Grader
FB is rated as a Strong Buy by means of the Portfolio Grader stock evaluator. With unique fundamental and quantitative metric based, this analytical tool evaluates nearly 5,000 stocks weekly. FB has been upgraded from a Buy to a Strong Buy in the last week.

High-Level Quant Score Make Citigroup (C) a Buy at recent price of $73.27

By Portfolio Grader
Portfolio Grader currently ranks C as a Buy. The system for investing incorporated in this analytical tool evaluates and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. The current Portfolio Grader recommendation on the shares has been in place for the last month.

Strong Quant Score Make Bristol-Myers Squibb Co (BMY) a Buy at recent price of $60.96

By Portfolio Grader
The a Buy rating for BMY is based on the Portfolio Grader stock evaluator. The methodology for investing incorporated in this analytical tool researches and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. BMY has maintained this ranking for the last month.

Earnings Growth Analytics Make AK Steel Holding (AKS) a Strong Sell at recent price of $4.65

By Portfolio Grader
The Strong Sell recommendation for AK Steel Holding Corp is the conclusion of an analytical process that is proprietary which yielded results that were below average in 6 areas: an economic sector ranked below average in attractiveness, an industry group ranked below average in attractiveness, a ranking in the company's sector that is in the bottom eighth, ranking in its industry group that is in the bottom eighth, analytical scoring that is below average, and a quantitative risk/reward calculation that is among the least attractive.

Ambev (ABEV) a Buy at recent price of $6.58, on Solid Earnings Momentum

By Portfolio Grader
The Buy recommendation for Ambev SA resulted from an analytical process that is proprietary which generated outcomes that were above average in 5 area: an economic sector rated above average in attractiveness, an industry group rated above average in attractiveness, a ranking in the company's sector that is in the top third, ranking in its industry group that is in the top half, and a mathematical computation of risk/reward that is attractive; and produced below average conclusions in 1 areas: an analytical score that is below average.

What to Expect From Nvidia Corporation’s Earnings

By Tom Taulli, InvestorPlace Contributor
Nvidia stock has run up against some volatility lately. Some of this has been due to the recent market drop. But there are also some analysts who are getting antsy. Yet it still looks like the long-term story for NVDA stock is intact.

GW Pharmaceuticals PLC – ADR (GWPH) Garners EMA Cannabidiol Approval

By Karl Utermohlen, InvestorPlace Writer
GW Pharmaceuticals (GWPH) has received review approval for the treatment of Epidiolex (cannabidiol), used to treat seizure patients with LGS and Dravet syndrome.

Fortinet Inc (FTNT) Adj. Earnings 3 Cents Above Estimates

By Karl Utermohlen, InvestorPlace Writer
Fortinet (FTNT) reported on its fourth quarter of fiscal 2018 after the bell Monday, unveiling adjusted earnings of 32 cents per share, three cents above estimates.

Gaming Rumors: New Crash Bandicoot Game Coming in 2019?

By Karl Utermohlen, InvestorPlace Writer
In the latest gaming rumors, a new 'Crash Bandicoot' game is reportedly coming in 2019. There's a renewed interest in the series since last year's 'N. Sane Trilogy.'

5 Value Stocks Breaking Out Right Now

By
You don’t have to pay 30x earnings to get a stock that is hitting new 52-week highs. Compare Brokers...

Bunge Ltd Stock Surges on Archer Daniels Deal Buzz

By William White, InvestorPlace Writer
Bunge (BG) stock was up today on a report that Archer Daniels (ADM) is in the advanced stage of talks to buy the company.
Load More Articles